Erratum: The novel BH-3 mimetic apogossypolone induces Beclin-1-and ROS-mediated autophagy in human hepatocellular carcinoma cells (Cell Death and Disease (2013) 4 (e489) DOI: 10.1038/cddis.2013.17);The novel BH-3 mimetic apogossypolone induces Beclin-1- and ROS-mediated autophagy in human hepatocellular cells

Cell Death and Disease

Volumn 4, Issue 2, 2013, Pages

  Cheng, P ^a   Ni, Z ^a   Dai, X ^b   Wang, B ^a   Ding, W ^a   Rae Smith, A ^c   Xu, L ^c   Wu, D ^d   He, F ^a   Lian, J ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b CHONGQING NORMAL UNIVERSITY   (China)

^c UNIVERSITY OF KANSAS CANCER CENTER   (United States)

^d XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

ApoG2; Autophagy; HCC; ROS

Indexed keywords

ACETYLCYSTEINE; ANTINEOPLASTIC AGENT; APOGOSSYPOLONE; BECLIN 1; HIGH MOBILITY GROUP B1 PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BCL X; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ARTICLE; AUTOPHAGY; CARCINOMA CELL; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; GENE TRANSLOCATION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 84875993097     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.17     Document Type: Erratum

References (46)

1. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132: 2557-2576.
2. Sherman M. Epidemiology of hepatocellular carcinoma. Oncology 2010; 78(Suppl 1): 7-10.
3. Tanaka S, Arii S. Molecular targeted therapies in hepatocellular carcinoma. Semin Oncol 2012; 39: 486-492.
4. Zender L, Spector MS, Xue W, Flemming P, Cordon-Cardo C, Silke J et al. Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell 2006; 125: 1253-1267.
5. Levine B, Sinha S, Kroemer G. Bcl-2 family members: dual regulators of apoptosis and autophagy. Autophagy 2008; 4: 600-606.
6. Kang MH, Reynolds CP. Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy. Clin Cancer Res 2009; 15: 1126-1132.
7. Warr MR, Shore GC. Small-molecule Bcl-2 antagonists as targeted therapy in oncology. Curr Oncol 2008; 15: 256-261.
8. Sun Y, Wu J, Aboukameel A, Banerjee S, Arnold AA, Chen J et al. Apogossypolone, a nonpeptidic small molecule inhibitor targeting Bcl-2 family proteins, effectively inhibits growth of diffuse large cell lymphoma cells in vitro and in vivo. Cancer Biol Ther 2008; 7: 1418-1426.
9. Arnold AA, Aboukameel A, Chen J, Yang D, Wang S, Al-Katib A et al. Preclinical studies of Apogossypolone: a new nonpeptidic pan small-molecule inhibitor of Bcl-2, Bcl-XL and Mcl- 1 proteins in follicular small cleaved cell lymphoma model. Mol Cancer 2008; 7: 20.
10. Mi JX, Wang GF, Wang HB, Sun XQ, Ni XY, Zhang XW et al. Synergistic antitumoral activity and induction of apoptosis by novel pan Bcl-2 proteins inhibitor apogossypolone with adriamycin in human hepatocellular carcinoma. Acta Pharmacol Sin 2008; 29: 1467-1477.
11. Banerjee S, Choi M, Aboukameel A,Wang Z, Mohammad M, Chen J et al. Preclinical studies of apogossypolone, a novel pan inhibitor of bcl-2 and mcl-1, synergistically potentiates cytotoxic effect of gemcitabine in pancreatic cancer cells. Pancreas 2010; 39: 323-331.
12. Chen N, Karantza V. Autophagy as a therapeutic target in cancer. Cancer Biol Ther 2011; 11: 157-168.
13. Niu X, Li S, Wei F, Huang J, Wu G, Xu L et al. Apogossypolone induces autophagy and apoptosis in breast cancer MCF-7 cells in vitro and in vivo. Breast Cancer 2012; doi:10.1007/s12282-012-0372-z.
14. Zhang XQ, Huang XF, Hu XB, Zhan YH, An QX, Yang SM et al. Apogossypolone, a novel inhibitor of antiapoptotic Bcl-2 family proteins, induces autophagy of PC-3 and LNCaP prostate cancer cells in vitro. Asian J Androl 2010; 12: 697-708.
15. Wei J, Kitada S, Stebbins JL, Placzek W, Zhai D, Wu B et al. Synthesis and biological evaluation of Apogossypolone derivatives as pan-active inhibitors of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins. J Med Chem 2010; 53: 8000-8011.
16. Maiuri MC, Criollo A, Tasdemir E, Vicencio JM, Tajeddine N, Hickman JA et al. BH3-only proteins and BH3 mimetics induce autophagy by competitively disrupting the interaction between Beclin 1 and Bcl-2/Bcl-X(L). Autophagy 2007; 3: 374-376.
17. Sinha S, Levine B. The autophagy effector Beclin 1: a novel BH3-only protein. Oncogene 2008; 27(Suppl 1): S137-S148.
18. Sinha S, Colbert CL, Becker N, Wei Y, Levine B. Molecular basis of the regulation of Beclin 1-dependent autophagy by the gamma-herpesvirus 68 Bcl-2 homolog M11. Autophagy 2008; 4: 8.
19. Malik SA, Orhon I, Morselli E, Criollo A, Shen S, Marino G et al. BH3 mimetics activate multiple pro-autophagic pathways. Oncogene 2011; 30: 3918-3929.
20. Zubair H, Khan HY, Ullah MF, Ahmad A, Wu D, Hadi SM. Apogossypolone, derivative of gossypol, mobilizes endogenous copper in human peripheral lymphocytes leading to oxidative DNA breakage. Eur J Pharm Sci 2012; 47: 280-286.
21. Sikora MJ, Bauer JA, Verhaegen M, Belbin TJ, Prystowsky MB, Taylor JC et al. Antioxidant treatment enhances anti-tumor cytotoxicity of (-)-gossypol. Cancer Biol Ther 2008; 7: 767-776.
22. Tang D, Kang R, Livesey KM, Cheh CW, Farkas A, Loughran P et al. Endogenous HMGB1 regulates autophagy. J Cell Biol 2010; 190: 881-892.
23. Lian J, Karnak D, Xu L. The Bcl-2-Beclin 1 interaction in (-)-gossypol-induced autophagy versus apoptosis in prostate cancer cells. Autophagy 2010; 6: 1201-1203.
24. Lian J, Wu X, He F, Karnak D, Tang W, Meng Y et al. A natural BH3 mimetic induces autophagy in apoptosis-resistant prostate cancer via modulating Bcl-2-Beclin1 interaction at endoplasmic reticulum. Cell Death Differ 2011; 18: 60-71.
25. Germain M, Slack RS. MCL-1 regulates the balance between autophagy and apoptosis. Autophagy 2011; 7: 5.
26. Dash R, Azab B, Quinn BA, Shen X, Wang XY, Das SK et al. Apogossypol derivative BI- 97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7/IL-24- mediated toxicity. Proc Natl Acad Sci USA 2011; 108: 8785-8790.
27. Voss V, Senft C, Lang V, Ronellenfitsch MW, Steinbach JP, Seifert V et al. The pan-Bcl-2 inhibitor (-)-gossypol triggers autophagic cell death in malignant glioma. Mol Cancer Res 2010; 8: 1002-1016.
28. Diaz-Troya S, Perez-Perez ME, Florencio FJ, Crespo JL. The role of TOR in autophagy regulation from yeast to plants and mammals. Autophagy 2008; 4: 851-865.
29. Wang J, Whiteman MW, Lian H, Wang G, Singh A, Huang D et al. A non-canonical MEK/ ERK signaling pathway regulates autophagy via regulating Beclin 1. J Biol Chem 2009; 284: 21412-21424.
30. Wei Y, Pattingre S, Sinha S, Bassik M, Levine B. JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy. Mol Cell 2008; 30: 678-688.
31. Li Y, Luo Q, Yuan L, Miao C, Mu X, Xiao W et al. JNK-dependent Atg4 upregulation mediates asperphenamate derivative BBP-induced autophagy in MCF-7 cells. Toxicol Appl Pharmacol 2012; 263: 21-31.
32. Zhao M, Yang M, Yang L, Yu Y, Xie M, Zhu S et al. HMGB1 regulates autophagy through increasing transcriptional activities of JNK and ERK in human myeloid leukemia cells. BMB Rep 2011; 44: 601-606.
33. Wong CH, Iskandar KB, Yadav SK, Hirpara JL, Loh T, Pervaiz S. Simultaneous induction of non-canonical autophagy and apoptosis in cancer cells by ROS-dependent ERK and JNK activation. PLoS One 2010; 5: e9996.
34. Yuan Y, Xue X, Guo R-B, Sun X-L, Hu G. Resveratrol enhances the antitumor effects of temozolomide in glioblastoma via ROS-dependent AMPK-TSC-mTOR signaling pathway. CNS Neurosci Ther 2012; 18: 536-546.
35. Kang R, Livesey KM, Zeh HJ 3rd, Lotze MT, Tang D. HMGB1 as an autophagy sensor in oxidative stress. Autophagy 2011; 7: 8.
36. Sikora MJ, Bauer JA, Verhaegen M, Belbin TJ, Prystowsky MB, Taylor JC et al. Antioxidant treatment enhances anti-tumor cytotoxicity of (-)-gossypol. Cancer Biol Ther 2008; 7: 767-776.
37. Arinbasarova AY, Medentsev AG, Krupyanko VI. Gossypol inhibits electron transport and stimulates ROS generation in Yarrowia lipolytica mitochondria. Open Biochem J 2012; 6: 11-15.
38. Hu ZY, Wang J, Cheng G, Zhu XF, Huang P, Yang D et al. Apogossypolone targets mitochondria and light enhances its anticancer activity by stimulating generation of singlet oxygen and reactive oxygen species. Chin J Cancer 2011; 30: 41-53.
39. Dalby KN, Tekedereli I, Lopez-Berestein G, Ozpolat B. Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer. Autophagy 2010; 6: 322-329.
40. Baehrecke EH. Autophagy: dual roles in life and death? Nat Rev Mol Cell Biol 2005; 6: 505-510.
41. Kondo Y, Kondo S. Autophagy and cancer therapy. Autophagy 2006; 2: 85-90.
42. Schrier BP, Lichtendonk WJ, Witjes JA. The effect of N-acetyl-L-cysteine on the viscosity of ileal neobladder mucus. World J Urol 2002; 20: 64-67.
43. Conesa EL, Valero F, Nadal JC, Fenoy FJ, Lopez B, Arregui B et al. N-acetyl-L-cysteine improves renal medullary hypoperfusion in acute renal failure. Am J Physiol Regul Integr Comp Physiol 2001; 281: R730-R737.
44. Shimamoto K, Hayashi H, Taniai E, Morita R, Imaoka M, Ishii Y et al. Antioxidant N-acetyl- L-cysteine (NAC) supplementation reduces reactive oxygen species (ROS)-mediated hepatocellular tumor promotion of indole-3-carbinol (I3C) in rats. J Toxicol Sci 2011; 36: 775-786.
45. Lian J, Ni Z, Dai X, Su C, Smith AR, Xu L et al. Sorafenib sensitizes (-)-gossypol-induced growth suppression in androgen-independent prostate cancer cells via Mcl-1 inhibition and Bak activation. Mol Cancer Ther 2011; 11: 416-426.
46. Yan HL, Xue G, Mei Q, Wang YZ, Ding FX, Liu MF et al. Repression of the miR-17-92 cluster by p53 has an important function in hypoxia-induced apoptosis. EMBO J 2009; 28: 2719-2732.